Display options
Cite
Heidemann R, Zhang C, Qi H, et al. The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells. Cytotechnology. 2000;32(2):157-67doi: 10.1023/A:1008196521213.
Heidemann, R., Zhang, C., Qi, H., Larrick Rule, J., Rozales, C., Park, S., Chuppa, S., Ray, M., Michaels, J., Konstantinov, K., & Naveh, D. (2000). The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells. Cytotechnology, 32(2), 157-67. https://doi.org/10.1023/A:1008196521213
Heidemann, R, et al. "The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells." Cytotechnology vol. 32,2 (2000): 157-67. doi: https://doi.org/10.1023/A:1008196521213
Heidemann R, Zhang C, Qi H, Larrick Rule J, Rozales C, Park S, Chuppa S, Ray M, Michaels J, Konstantinov K, Naveh D. The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells. Cytotechnology. 2000 Feb;32(2):157-67. doi: 10.1023/A:1008196521213. PMID: 19002977; PMCID: PMC3449690.
Copy Download .nbib Format: NLM
Share it on

Cytotechnology. 2000 Feb;32(2):157-67. doi: 10.1023/A:1008196521213.

The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells.

Cytotechnology

R Heidemann, C Zhang, H Qi, J Larrick Rule, C Rozales, S Park, S Chuppa, M Ray, J Michaels, K Konstantinov, D Naveh

Affiliations

  1. Bayer Corporation, 800 Dwight Way, P.O. Box 1686, Berkeley, CA, 94701, USA, [email protected].

PMID: 19002977 PMCID: PMC3449690 DOI: 10.1023/A:1008196521213

Abstract

Protein hydrolysates as substitutes for serum havebeen employed by many in cell culture mediumformulation, especially with the shift to low proteinor protein-free media. More recently, vegetablehydrolysates have also been added as nutritionalsupplements to fortify the amino acid content in smallpeptide form for batch and fed-batch fermentations. Several of these new hydrolysates (peptones of soy,rice, wheat gluten etc.) were tested as protein-freemedium supplements for the production of a recombinanttherapeutic protein. Multiple peptone-supplemented,continuous perfusion bioreactor experiments wereconducted, varying dilution rates and basal mediumcomposition over the various runs. Cell specificrates and product quality studies were obtained forthe various peptones and compared with peptone-freemedium. The potential for peptones to decreaseintrinsic and proteolytic degradation of the productwas also investigated.It was found that peptones confer a nutritionalbenefit, especially at low dilution rates, for therecombinant BHK cell line used in this investigation.The specific productivity increased 20-30% comparedto the peptone-free controls. However, this benefitwas also fully delivered by using fortified medium inplace of the peptone-enriched media. Therefore, whilepeptones may be considered as useful medium additiveswhen development time is limited, their addition maybe avoided by systematic medium development ifpermitted by the time line of the project.

References

  1. Cytotechnology. 1994;16(3):147-50 - PubMed
  2. Proc Natl Acad Sci U S A. 1988 May;85(10):3289-93 - PubMed
  3. Cytotechnology. 1995 Oct;17(3):153-63 - PubMed
  4. Am J Physiol. 1986 Dec;251(6 Pt 2):F945-53 - PubMed
  5. Am J Physiol. 1991 Oct;261(4 Pt 2):F670-8 - PubMed
  6. FASEB J. 1995 Nov;9(14):1489-96 - PubMed
  7. J Biol Chem. 1983 Dec 10;258(23):14189-92 - PubMed
  8. Cytotechnology. 1991 Oct;7(2):63-74 - PubMed
  9. Biotechnol Bioeng. 1996 May 5;50(3):299-318 - PubMed
  10. Cytotechnology. 1991 Jan;5(1):57-67 - PubMed
  11. Cytotechnology. 1994 Jan;16(1):37-42 - PubMed
  12. Biotechnol Bioeng. 1997 Dec 5;56(5):577-82 - PubMed
  13. Biotechnol Bioeng. 1997 Nov 20;56(4):353-60 - PubMed
  14. J Biotechnol. 1994 May 31;34(3):247-57 - PubMed
  15. Am J Physiol. 1987 Sep;253(3 Pt 2):F448-57 - PubMed
  16. Am J Physiol. 1995 Mar;268(3 Pt 2):F391-7 - PubMed
  17. Biochim Biophys Acta. 1995 Nov 22;1240(1):1-4 - PubMed
  18. Dev Biol Stand. 1987;66:263-8 - PubMed
  19. J Immunol Methods. 1996 Aug 14;194(2):191-9 - PubMed
  20. Cytotechnology. 1998 May;26(3):185-97 - PubMed
  21. Biotechnol Bioeng. 1997 Jul 20;55(2):328-38 - PubMed
  22. Cytotechnology. 1994;16(1):17-26 - PubMed
  23. Cytotechnology. 1991 Sep;7(1):15-24 - PubMed
  24. Biotechnol Bioeng. 1999 Feb 5;62(3):324-35 - PubMed

Publication Types